Nu-Med Plus (NUMD) Preferred Shares (2025 - 2026)
Nu-Med Plus' (NUMD) quarterly Preferred Shares came in at $10.0 million in Q2 2026, little changed quarter-over-quarter from $10.0 million in Q4 2025.
Powered by 
Analysis
Nu-Med Plus (NUMD) Preferred Shares (2025 - 2026) Analysis & Trends
Nu-Med Plus has disclosed Preferred Shares across 2 years of filings, most recently posting $10.0 million for Q2 2026.
- In Q2 2026, Preferred Shares changed N/A year-over-year to $10.0 million; the TTM figure through Jun 2026 stood at $10.0 million (changed N/A YoY), while the FY2025 annual figure was $10.0 million, changed N/A from the prior year.
- Preferred Shares came in at $10.0 million for Q2 2026 at Nu-Med Plus, roughly flat from $10.0 million in the prior quarter.
- In the past five years, Preferred Shares ranged from a high of $10.0 million in Q4 2025 to a low of $10.0 million in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Preferred Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 179.79 Bn | 174.18 Bn | 7.27 Bn | - |
| 2 | Intuitive Surgical | 127.69 Bn | 122.47 Bn | 1.96 Bn | - |
| 3 | Medtronic | 117.23 Bn | 108.41 Bn | 6.34 Bn | - |
| 4 | Stryker | 103.55 Bn | 100.07 Bn | 4.50 Bn | - |
| 5 | Boston Scientific | 63.24 Bn | 62.70 Bn | 3.85 Bn | - |
| 6 | Edwards Lifesciences | 49.97 Bn | 45.72 Bn | 1.35 Bn | - |
| 7 | Alcon | 32.83 Bn | 31.37 Bn | 1.68 Bn | - |
| 8 | Dexcom | 32.30 Bn | 30.35 Bn | 830.00 Mn | - |
| 9 | Steris | 20.73 Bn | 20.25 Bn | 684.20 Mn | - |
| 10 | Nu-Med Plus | 1.67 Mn | 1.67 Mn | - | 10.00 Mn |